Jill Regan, LexisNexis Risk Solutions - Health Care's director of relationship management, details how automated prescriber verification can help pharmacies save time and headaches when it comes to prescriber data.
DSN editor in chief Seth Mendelson looks at how CVS Health is approaching healthcare and the impact it had on the company's bottom line in the third quarter.
Pharmacy consultant and industry expert Bruce Kneeland takes a look at an independent PBM business model focused on saving money and improving patient outcomes.
David Orgel highlights some recent efforts by retailers to boost their employee benefits — from innovative training to education — to attract and retain talent.
Health Mart Atlas vice president of pharmacy performance Crystal Lennartz discusses industry-wide efforts McKesson is participating in to help bring about DIR fee reform.
DisposeRx founder and CEO John Holaday highlights the ways that pharmacies can play a role in helping patients safely dispose of unused and unwanted medication to prevent abuse and misuse.
The current growth in the men’s personal care and grooming market highlights a shift in the way that male consumers traditionally have approached their personal care. Previously, men have shopped based on utility, with very little research behind the purchase required.
PowerReviews’ Cheryl Sullivan writes about the important role that consumer-generated brand content can play in building a private-label OTC strategy to take on Amazon.
National Association of Chain Drug Stores president and CEO Steve Anderson discusses how NACDS is advancing pharmacy’s partnership, in policy and practice in combating opioid abuse and addiction.
Drug Store News editor in chief Seth Mendelson discusses how retailers don’t necessarily need to scrap their tried-and-true playbook for new generations.
Rite Aid senior vice president and chief human resources officer Jessica Kazmaier discusses how the chain is investing in its associates to create a customer experience that will help it navigate its “Path to the Future.”
This month, David Orgel examines an element of retailing that long has been a cornerstone of the industry — a smiling associate — and how retailers can reevaluate what they want from associates in an age of authenticity.
Fred Mayer, CEO of Pharmacists Planning Services, explains how as the political healthcare debate rages on, many of the “first-world” problems that cause illness and compromise our quality of life are problems pharmacists can help solve.
The conversation at the pharmacy counter traditionally has been about which pills to take when, but with advances in medical science, a new frontier — biologics and biosimilars — is flourishing, explains Chip Davis, president and CEO of the Association for Accessible Medicines.
Chris Fitzmaurice, director of industry data resources at ScriptPro, explains why pharmacists should accept a greater measure of responsibility and continue to accept the demands of medical professionals, as well as expand on what it means to provide pharmaceutical care.
William Sieber, president of E. F. Bavis and Associates, explains how the pharmacist-patient relationship requires the sharing of concise and detailed information, which can include times, dosage amounts, possible interactions with other medications, and more.
Simplifying the pharmacy payment model is an enormous undertaking that will necessitate participation from all players in the prescription medication channels, according to Doug Hoey, CEO of the National Community Pharmacists Association.
Through thoughtful design features that addressed injection therapy obstacles, Owen Mumford brought to market a product that made injection therapy easier, safer and more convenient, explains Casey Pflieger, director of North American marketing at Owen Mumford.
